Variable | No Sarcopenia (n = 112) | Sarcopenia (n = 23) | P-value | Effect size** | Post-Hoc Power analysis** | ||
---|---|---|---|---|---|---|---|
Baseline data | |||||||
Age (years)†| 69 (50–80) | 67 (57–80) | 0.907§ | NA | NA | ||
Sex‡ | Female | 55 (49.1) | 10 (43.5) | 0.623¶ | NA | NA | |
Male | 57 (50.9) | 13 (56.5) | |||||
BMI (kg/m2)†| 25.9 (17.7—37.6) 95% CI: 23.18 to 28.62 | 21.9 (13.6—33.0) 95% CI: 16.04 to 27.76 |  < 0.001§ | 0.3* | 85% | ||
Nutritional status†| Total water | 29.3 (25–56) 95% CI: 25.05 to 33.55 | 27.1 (22.1—38.2) 95% CI: 22.22 to 31.98 |  < 0.001§ | 0.2* | 65% | |
Protein | 8.4 (6.5—16.6) 95% CI: 7.01 to 9.79 | 6.8 (5.7—8.9) 95% CI: 5.84 to 7.76 |  < 0.001§ | 0.4* | 95% | ||
Minerals | 2.9 (2.2—4.5) 95% CI: 2.59 to 3.21 | 2.5 (1.9—3.5) 95% CI: 2.01 to 2.99 |  < 0.001§ | 0.3* | 85% | ||
body composition and muscle performance | |||||||
SMM†| 23 (14.2—46.1) 95% CI: 18.2 to 27.8 | 14.8 (13.3—19.8) 95% CI: 12.7 to 16.9 |  < 0.001§ | 0.6* | 99% | ||
Fat mass†| 24.3 (2.4—48) 95% CI: 17.5 to 31.1 | 18.8 (1.1—28.3) 95% CI: 9.9 to 27.8 | 0.003§ | 0.5* | 98% | ||
BMR†| 1276 (1056–2039) 95% CI: 1129.2 to 1422.8 | 1134 (1025–1397) 95% CI: 1011.6 to 1256.4 |  < 0.001§ | 0.6* | 99% | ||
Handgrip strength (kg)†| 20 (10–50) 95% CI: 14.03 to 25.97 | 16 (10–30) 95% CI: 9.4 to 22.6 | 0.034§ | 0.3* | 85% | ||
SARC-F score‡ | |||||||
Strength | Not at all | 93 (83%) | 15 (65.2%) | 0.019¶ | NR | NR | |
Some difficulty | 16 (14.3%) | 4 (17.4%) | |||||
Very difficult | 3 (2.7%) | 4 (17.4%) | |||||
Assistance walking | Not at all | 99 (88.4%) | 16 (69.6%) | 0.016¶ | |||
Some difficulty | 10 (8.9%) | 3 (13%) | |||||
Very difficult | 3 (2.7%) | 4 (17.4%) | |||||
Rising from a chair | Not at all | 98 (87.5%) | 17 (73.9%) | 0.020¶ | |||
Some difficulty | 13 (11.6%) | 3 (13%) | |||||
Very difficult | 1 (0.9%) | 3 (13%) | |||||
Climbing stairs | Not at all | 90 (80.4%) | 15 (65.2%) | 0.013¶ | |||
Some difficulty | 13 (11.6%) | 1 (4.3%) | |||||
Very difficult | 9 (8.0%) | 7 (30.4%) | |||||
Falls | None | 67 (59.8%) | 11 (47.8%) | 0.204¶ | |||
1–3 times | 25 (22.3%) | 4 (17.4%) | |||||
 > 3 times | 20 (17.9%) | 8 (34.8%) | |||||
Sum SARC-F | Normal (0—3 points) | 99 (88.4%) | 16 (69.6%) | 0.046¶ | OR: 3.33# RD: 0.188# | 65% | |
Abnormal (≥ 4 points) | 13 (11.6%) | 7 (30.4%) |